StarFish Medical Hosts Live Webinar on the Realities Behind Major MedTech Transactions
Behind the Deal brings together StarFish Medical CEO Scott Phillips and Lumira Ventures’ Peter van der Velden for an inside look at MedTech M&A strategy
Victoria, BC (February 12) StarFish Medical, a leading MedTech design and development partner, today announced an upcoming live webcast, Behind the Deal: Inside Major MedTech Transactions, taking place on Thursday, February 26, 2026, at 12:00 pm ET / 9:00 am PT.
As MedTech founders and executives face a more selective and complex transaction environment, understanding how major deals actually come together has never been more important. In this live interview-style webcast, Scott Phillips, CEO of StarFish Medical, will sit down with Peter van der Velden, Managing General Partner at Lumira Ventures, to explore the strategic realities behind recent high-profile MedTech transactions.
Drawing from real-world deal experience, the conversation will go beyond headlines and valuation figures to examine the decisions, timing, and trade-offs that shape successful outcomes. Topics will include how early strategic choices influence exit options, how market conditions affect deal timing, and what founders and executive teams should be thinking about well before a transaction is formally on the table.
The session will also include a live audience Q&A, giving attendees the opportunity to ask candid questions and gain practical insight into today’s MedTech deal landscape.
This webcast is designed for MedTech founders, executives, and leadership teams who want a clearer, experience-based perspective on acquisitions, partnerships, and strategic transactions.
Registration is now open. Interested participants can reserve their spot online.
Presenter Bios:
Peter van der Velden
Peter van der Velden is the Managing General Partner of Lumira Ventures, one of North America’s leading life sciences venture capital firms focused on identifying and building transformative biopharmaceutical, medtech, and digital health companies. He has more than 30 years of experience as an investor and operator, partnering with mission-driven entrepreneurs to grow innovative healthcare companies from early-stage through expansion and exit.
Under his leadership, Lumira has become one of the most active life sciences investors in Canada and across North America, raising significant capital and supporting numerous successful companies. Peter is widely recognized for his strategic vision, deep industry expertise, and commitment to advancing healthcare innovation and the broader startup ecosystem. He also serves on multiple boards and has played a prominent role in industry associations, including leadership positions with the Canadian Venture Capital & Private Equity Association.
Scott Phillips
Scott holds a degree in Engineering Physics from the University of British Columbia. Prior to starting StarFish, he worked in diverse areas such as lithium battery development and manufacturing, UV spectroscopy instrumentation and hi-fi audio speakers. Under his leadership StarFish has grown into a diverse professional organization with clients around the world and 100% focus on medical devices. Scott is a past Chair and current member of the LifeSciences British Columbia board, member of the 2022 VIATEC Board of Directors, Fellow of The Canadian Academy of Engineering, winner of the EY Entrepreneur Of The Year™ 2017 Pacific Awards Technology category, 2017 recipient of the VIATEC Technology Champion award, and volunteers with Junior Achievement, Entrepreneurs Organization, and University of British Columbia.